Journal ArticleOPEN ACCESS

State of the Science and Future Directions for Liquid Biopsies in Drug Development

  • Narayan P
  • Ghosh S
  • Philip R
  • et al.
The Oncologist (2020) 25(9) 730-732
DOI: 10.1634/theoncologist.2020-0246
13Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

With advances in precision oncology, liquid biopsies have shown promise as a minimally invasive means to diagnose cancer and guide treatment decisions. This commentary presents an assessment of the potential and the challenges of widespread use of liquid biopsy testing, based on the 2019 Accelerating Anticancer Agent Development Workshop.

Cite

CITATION STYLE

APA

Narayan, P., Ghosh, S., Philip, R., Barrett, J. C., McCormack, R. T., Odegaard, J. I., … Beaver, J. A. (2020). State of the Science and Future Directions for Liquid Biopsies in Drug Development. The Oncologist, 25(9), 730–732. https://doi.org/10.1634/theoncologist.2020-0246

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free